What Type of Injection is Ozempic and How Does It Work?

Last reviewed: July 6, 2026

Last updated: July 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, which work by activating receptors in your brain and gut that control hunger signals. Originally developed to treat type 2 diabetes, semaglutide has demonstrated significant weight loss effects in clinical trials, with patients losing an average of 15% of body weight over 68 weeks. Understanding how this injection works can help you make an informed decision about whether it aligns with your weight loss goals.

What Type of Injection Is Semaglutide?

Semaglutide is a subcutaneous injection, meaning it is administered just under the skin rather than into muscle or vein. You inject it once weekly using a pen device or small needle into your abdomen, thigh, or upper arm—areas with sufficient fatty tissue for proper absorption. The injection delivers a synthetic version of glucagon-like peptide-1 (GLP-1), a hormone your body naturally produces after eating.

Unlike insulin, which requires precise timing around meals, semaglutide works continuously throughout the week once injected. Each dose is pre-measured and standardized, eliminating the need for calculations. Most patients find the injection process quick and relatively painless, with the needle being much finer than those used for blood draws.

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and sterility. This approach allows for customizable formulations while maintaining strict safety standards, without requiring insurance or membership fees.

How Semaglutide Works in Your Body

Once injected, semaglutide travels through your bloodstream and binds to GLP-1 receptors located in your brain, pancreas, and digestive tract. This activation triggers multiple weight-loss mechanisms simultaneously: it slows gastric emptying (the rate at which food leaves your stomach), increases feelings of fullness after smaller portions, and reduces cravings for high-calorie foods. The medication essentially reprograms your appetite control center.

Semaglutide also improves insulin secretion in response to meals, helping stabilize blood sugar levels and reduce energy crashes that typically trigger hunger. In the pancreas, it stimulates insulin production when glucose is elevated and suppresses glucagon release when blood sugar drops, creating a balanced metabolic state. These combined effects explain why users often report eating significantly less without feeling deprived.

The medication reaches peak concentration in your bloodstream about 24-48 hours after injection, then gradually decreases over the following days. By the time you inject again the following week, your body maintains a consistent therapeutic level, which is why weekly dosing is effective and convenient.

Clinical Evidence Behind Semaglutide's Effectiveness

The STEP clinical trials, which included over 4,500 participants, demonstrated that semaglutide injection produced average weight loss of 9.3 kg (20.5 lbs) over 68 weeks in adults with obesity. Participants on the highest dose lost approximately 15% of their baseline body weight, compared to just 2.6% in the placebo group. These results were sustained for at least one year of continued treatment, with many patients maintaining their weight loss without regaining pounds.

Beyond weight reduction, semaglutide showed cardiovascular benefits in the SELECT trial, reducing the risk of heart attacks, strokes, and cardiovascular death by 20% in people with established heart disease or risk factors. This suggests the medication offers protection beyond weight loss alone. Studies also document improvements in blood pressure, cholesterol levels, and insulin sensitivity.

The medication's effect on appetite regulation is so pronounced that many patients report naturally gravitating toward smaller portions and healthier food choices without conscious restriction. Brain imaging studies confirm that semaglutide alters activity in regions controlling hunger and reward, providing a biological explanation for these behavioral changes.

Personalized Semaglutide Therapy With Genetic Testing

Individual responses to semaglutide vary significantly based on genetic variations in appetite-regulation pathways. PlexusDx's Precision Peptide Genetic Test identifies key variants such as FTO rs9939609, which influence how your body responds to GLP-1 receptor agonists and metabolizes fat. Understanding your genetic profile helps optimize your treatment protocol before starting.

The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx offers the Precision Peptide Genetic Test for $298, allowing your provider to refine your semaglutide protocol based on your unique biology. This personalization transforms weight loss from a one-size-fits-all approach into a strategy tailored to your genetic predispositions.

Getting Started With Compounded Semaglutide at PlexusDx

PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required, membership fees, or hidden costs. The pricing remains flat regardless of your dose level—your dose may need to go up as your treatment progresses, but your price won't. All medications originate from licensed 503A compounding pharmacies that meet stringent FDA oversight and quality standards.

To begin, you'll complete a health assessment with a PlexusDx provider who reviews your medical history, current medications, and weight loss goals. If semaglutide is appropriate, your provider develops a personalized titration schedule, typically starting at 0.25 mg weekly and increasing gradually over 4-5 weeks to minimize side effects. You'll receive guidance on proper injection technique, storage, and what to expect.

PlexusDx serves all 50 states and accepts HSA and FSA funds, making treatment accessible and affordable. Your provider monitors your progress through follow-up appointments and can adjust your protocol based on your response. If genetic testing reveals that your results would improve with a different medication, your provider can transition you to oral semaglutide, tirzepatide, or the dual-compound GLP-Squared protocol without penalty.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How often do I need to inject semaglutide?

Semaglutide is injected once per week, on the same day each week. You self-administer the subcutaneous injection using a pre-filled pen, which most patients complete in under 30 seconds. The weekly schedule makes it easier to remember than daily medications and provides consistent therapeutic levels throughout the week.

What is the difference between semaglutide and tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

How quickly will I see weight loss results from semaglutide?

Most patients notice reduced appetite and portion control within 1-2 weeks of starting semaglutide. Measurable weight loss typically appears within 3-4 weeks, with more significant results accumulating over 8-12 weeks. Individual timelines vary based on genetics, diet, activity level, and starting dose.

What are common side effects of semaglutide injections?

Nausea is the most common side effect, affecting 25-40% of users, especially during the first 2-4 weeks. Other side effects include vomiting, constipation, diarrhea, and fatigue. Most side effects are mild, temporary, and managed through gradual dose increases and dietary adjustments. Serious complications like pancreatitis are rare but require immediate medical attention.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Injection Ozempic
• Ozempic For Type 2 Diabetes 2
• Injection Sites For Ozempic
• Ozempic What Is It

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.